drugset / Trial / NCT07363551

Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression

NCT07363551

Recruiting 60 enrolled China Medical University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder

Timeline

Start
2021-06-09
Primary completion
2026-05-31
Completion
2026-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3 fatty acids Unknown